Overview

The Health Insurance (Endovenous Laser Therapy) Determination 2012 (No.2) was enacted to provide legal authority for the annual indexation of Medicare Benefits Schedule (MBS) fees for endovenous laser therapy (ELT) services, specifically items 32520 and 32522, from 1 November 2012. This Determination was introduced in response to the need for an alternative minimally invasive procedure to in-hospital vein stripping for treating severe varicose veins, and it is a legislative instrument for the purposes of the Legislative Instruments Act 2003. The policy objective is to ensure that the Medicare benefits for ELT services are equivalent to the in-hospital comparator and to cap Extended Medicare Safety Net (EMSN) benefits for these services. The Determination was enacted by the relevant Minister under Subsection 3C(1) of the Health Insurance Act 1973, following approval in the 2011-2012 Budget and endorsement by the Medical Services Advisory Committee (MSAC) in December 2009.

Scope and Application

The Health Insurance (Endovenous Laser Therapy) Determination 2012 (No.2) applies to the Medicare Benefits Schedule (MBS) fees for items 32520 and 32522 concerning endovenous laser therapy (ELT), a minimally invasive procedure for treating severe varicose veins. This Determination operates under the authority granted by Subsection 3C(1) of the Health Insurance Act 1973, allowing the Minister to specify that certain health services, not already listed in the General Medical Services Table, will be treated as if they were listed under specified conditions. This legislation is applicable nationally across Australia, as it falls under the Commonwealth jurisdiction, and it applies to medical practitioners and patients who utilise the specified ELT services. The Determination ensures that the MBS fees for these services are indexed annually, aligning with the fees for other services in the General Medical Services Table, and it revokes the previous Health Insurance (Endovenous Laser Therapy) Determination 2012, effective from 1 November 2012. There are no exclusions or exemptions stated in the Determination, and it functions as a legislative instrument under the Legislative Instruments Act 2003.

Key Provisions

The Health Insurance (Endovenous Laser Therapy) Determination 2012 (No.2) (the Determination) (sections 1-5) outlines the legislative framework for the annual indexation of fees for endovenous laser therapy (ELT) services from 1 November 2012. The Determination specifies that the relevant services (items 32520 and 32522) are to be treated as if they were specified in the General Medical Services Table (the Table) under the Health Insurance Act 1973 (the Act). This means that ELT services will be recognised as professional and medical services for the purposes of the Act and related regulations (section 5(a)). Furthermore, these services will be treated as if there were corresponding entries in the Table with fees specified in the Schedule to the Determination (section 5(b)). The Determination imposes specific obligations on healthcare providers and patients to ensure that the ELT services are delivered and billed in compliance with the Act and the Medicare Benefits Schedule (MBS). Healthcare providers must ensure that the services rendered are appropriately documented and that claims submitted to Medicare reflect the correct item numbers and fees as indexed under the Determination (section 5). Patients, on the other hand, are required to understand that the services they receive under these items are subject to the same conditions and limitations as other MBS-listed services, including any applicable gaps in the Medicare Safety Net (section 5). Breaches of the provisions under the Determination may result in legal consequences. While the Determination itself does not explicitly outline offences or penalties, violations of the Act or related regulations could lead to financial penalties, legal action, or other civil or criminal consequences as provided under the overarching legislative framework. For instance, submitting false claims or providing services that do not meet the criteria set out in the Determination could be considered fraudulent activities under the Commonwealth Criminal Code, attracting penalties such as fines or imprisonment. Additionally, failure to comply with the MBS requirements may result in the provider being liable for the full cost of the services provided to the patient. In summary, the Health Insurance (Endovenous Laser Therapy) Determination 2012 (No.2) provides the legislative basis for the annual indexation of fees for ELT services, ensuring they are recognised as professional and medical services under the Act. It imposes clear obligations on healthcare providers and patients to ensure compliance with the MBS and the Determination. Breaches of the Act or related regulations may result in significant penalties, including fines and imprisonment for fraudulent activities, as well as civil consequences such as financial liability for non-compliant services.